Author

Varsha Parulekar

OpenAlex ID: A5019231629

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

2011 · Samba O. Sow, Brown J. Okoko, et al. · New England Journal of Medicine · 178

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

2017 · Prasad S. Kulkarni, Sajjad Desai, et al. · Vaccine · 138

PDF

Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study

2017 · Nithya J Gogtay, Renuka Munshi, et al. · Clinical Infectious Diseases · 91

PDF

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

2007 · Nilima Kshirsagar, Naidu Mur, et al. · Vaccine · 82

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

2015 · Chetan E. Chitnis, Paushali Mukherjee, et al. · PLoS ONE · 47

PDF

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial

2012 · Siddhivinayak Hirve, Ashish Bavdekar, et al. · Vaccine · 29

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

2015 · Aldiouma Diallo, Samba O. Sow, et al. · Clinical Infectious Diseases · 23

PDF

Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants

2019 · Anand Kawade, Sudhir Babji, et al. · Vaccine · 19

Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine

2014 · Prasad S Kulkarni, Sharad Agarkhedkar, et al. · Human Vaccines & Immunotherapeutics · 19

PDF

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

2015 · Milagritos D. Tapia, Helen Findlow, et al. · Clinical Infectious Diseases · 17

PDF

Meningococcal Group C and W135 Immunological Hyporesponsiveness in African Toddlers

2011 · Helen Findlow, Samba Sow, et al. · Clinical and Vaccine Immunology · 13

Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

2015 · Chetan E. Chitnis, Paushali Mukherjee, et al. · PLoS ONE · 10

PDF

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study

2024 · Prasad S Kulkarni, Anand Kawade, et al. · The Lancet Infectious Diseases · 9

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians

2015 · Milagritos D. Tapia, Samba O. Sow, et al. · Clinical Infectious Diseases · 6

PDF

Changes in immunological parameters by ageing in rural healthy Indian adults and their associations with sex and lifestyle

2022 · Dhiraj Agarwal, Sourav Paul, et al. · Scientific Reports · 5

PDF

Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial

2025 · Prasad S Kulkarni, Khalequ Zaman, et al. · The Lancet Infectious Diseases · 4

Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers

2025 · Abraham Hodgson, Fadima Cheick Haidara, et al. · Vaccine

Changes in Immunological Parameters by Aging in Rural Healthy Indian Adults and their Associations with Sex and Lifestyle

2022 · Dhiraj Agarwal, Sourav Paul, et al. · Research Square

PDF

Works count: 20

Citation count: 690

H-index: 11

I10-index: 12